0
Applied AI·September 16, 2026·1 min read

Novo Will Work With Anthropic AI to Speed Drug Development

Share

Novo Nordisk teaming with Anthropic to accelerate drug development shows big pharma is now comfortable treating frontier models as core R&D tools, not side experiments. If you sell into life sciences, assume AI-native workflows will become table stakes—your edge is domain-specific data, validation, and regulatory fit.

Applied AI

Sources: OpenAI and Anthropic staff felt blindsided by Dario Amodei's and Sam Altman's calls to slow the frontier; some fear evaluators may compromise security

Internal pushback at OpenAI and Anthropic over public calls to "slow the frontier" shows how misaligned incentives can get between leadership, safety teams, and researchers. If you’re building advanced AI internally, formalize who owns slowdown decisions, how evaluators are vetted, and how you communicate risk posture to your own staff before regulators force the issue.

Applied AI

Sources: Apple is developing enterprise AI servers powered by two or four M8 Ultra chips, set for 2029, and is considering integrating Nvidia's NVLink Fusion

Apple exploring M8 Ultra-based enterprise AI servers for 2029 is a long-dated bet that vertical integration will matter even in the data center, not just on-device. If they pair their own silicon with Nvidia’s NVLink Fusion, expect a hybrid world where proprietary stacks still need to interoperate with the dominant accelerator ecosystem.